Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a simple roadside test catch liver disease before it turns deadly?

NCT ID NCT06755632

Recruiting now Knowledge-focused Sponsor: Assistance Publique - Hôpitaux de Paris Source: ClinicalTrials.gov ↗

First seen Jul 23, 2026 · Last updated Jul 24, 2026 · Updated 1 time

Summary

This study aims to find undiagnosed cases of advanced liver fibrosis and viral hepatitis B and C in the general population of Seine Saint Denis, France. Using a combination of rapid diagnostic tests and a portable liver stiffness scanner (FibroScan), researchers will screen 600 adults in community settings. The goal is to measure how common these conditions are and to refer people who test positive to specialist care.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this screening approach could identify many undiagnosed cases of liver disease and connect people to care earlier, potentially reducing complications and deaths.
What could go wrong
This is an observational screening study, not a treatment trial. It will measure how common liver fibrosis and hepatitis are, but it does not test any new therapy or intervention.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADVANCED LIVER FIBROSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cirrhosis of liver Fibrosis fibrotic liver disease hepatitis B virus infection hepatitis C virus infection liver disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

LIVER PATHOLOGY

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Avicenne Hospital

    RECRUITING

    Bobigny, 93000, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Hepatology department -Hospital Avicenne

    WITHDRAWN

    Bobigny, 93100, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.